Clinical Trial Update: Zaleplon in HIV Patients With Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating zaleplon in HIV patients with depression has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids
• Major Depressive Disorder

Drugs mentioned

• Zaleplon (Zaleplon)

Snippet

Sponsor: University of Pennsylvania | Conditions: HIV/AIDS, Clinical Depression | Phase 2 | Status: COMPLETED | Results posted: 2018-09-18